<html lang="en-US">
	
<!-- Mirrored from edu.szmdata.com/Readings/Doc/31022_011_Q.html by HTTrack Website Copier/3.x [XR&CO'2014], Mon, 03 Jun 2024 12:32:43 GMT -->
<head>
		<meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=0.5, maximum-scale=2.0, user-scalable=yes" content="target-densitydpi=device-dpi" />
		<meta http-equiv="Content-Type" content="text/html;charset=utf-8" />
		<title>Passage 31022_011_Q</title>
		<link rel="stylesheet" href="../../COMMON/CSS/styles.css" />
		<script language="JavaScript" src="../../COMMON/JS/popup.js"></script>
	</head>
	<body>



	<p class="stems">81. The name of the new prostate cancer drug is ____.</p>
		<ol type="A">
			<li>therapeutic cancer vaccine</li>
			<li>unknown</li>
			<li>Dendreon</li>
			<li key="1"><span>Provenge</span></li>
		</ol>

	<p class="stems">82. The FDA could be criticized ____.</p>
		<ol type="A">
			<li key="1"><span>for its turning-down the license for Provenge</span></li>
			<li>because of an endorsement by one of the agency's advisory committees</li>
			<li>owing to patients' own immune system to fight the cancer</li>
			<li>because of the two-week spaced treatment of prostate cancer</li>
		</ol>

	<p class="stems">83. Two prostate cancer experts hired bodyguards attending a major conference ____.</p>
		<ol type="A">
			<li key="1"><span>because they had been threatened for recommending the FDA to deny the drug trial</span></li>
			<li>after the FDA's decision two years ago agitated prostate cancer patients and investors</li>
			<li>before the FDA had delayed the production of the prostate cancer vaccine</li>
			<li>when investors from Dendreon denied prostate cancer patients a potential treatment</li>
		</ol>

	<p class="stems">84. What does the author say about the results of the prostate cancer drug trial?</p>
		<ol type="A">
			<li>Patients no longer benefited from therapies intended to deprive the tumors of testosterone.</li>
			<li>Patients' cancer had spread beyond the prostate gland.</li>
			<li>Many investors bet on the failure of the drug in the clinical trial.</li>
			<li key="1"><span>The company did not disclose the results for some reason.</span></li>
		</ol>

	<p class="stems">85. Which of the following best describes the new prostate cancer drug trial?</p>
		<ol type="A">
			<li>Controversial.</li>
			<li>Notorious.</li>
			<li key="1"><span>Promising.</span></li>
			<li>Susceptible.</li>
		</ol>


		<p class="show">
		 <tt style="cursor: pointer"
			onmouseover="this.style.textDecoration='underline'"
			onmouseout="this.style.textDecoration='none'"
			onclick="showkey();"
		 >
			(Reference keys.)
		 </tt>
		</p>

	</body>

<!-- Mirrored from edu.szmdata.com/Readings/Doc/31022_011_Q.html by HTTrack Website Copier/3.x [XR&CO'2014], Mon, 03 Jun 2024 12:32:43 GMT -->
</html>
